Keurig Dr Pepper, US49271V1008

Keurig Dr Pepper stock gains on strong Q2 earnings and fresh institutional buying

Published on 09/08/2026 at 17:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Keurig Dr Pepper stock is trading near its 12-month high after a robust Q2 2026 earnings beat and new institutional buying, with the shares up more than 16 percent year to date and a market capitalization above USD 44 billion.

Moderne Getränkeabfüllanlage mit Edelstahl-Fließbändern und Mitarbeitern in Schutzkleidung
Fotorealistische Abfüllanlage zeigt Keurig Dr Pepper (ISIN US49271V1008) bei moderner Getränkeproduktion mit Edelstahl-Fließbändern und Mitarbeitern, Illustration mit AI erstellt.

Keurig Dr Pepper stock (ISIN US49271V1008) is trading close to its recent highs after a solid Q2 2026 earnings beat and fresh institutional buying interest, with the shares at USD 32.59 as of September 4, 2026, up about 16.4 percent since the start of the year according to market data.MarketBeat

Earnings beat and revenue surge underpin the move

According to a recent institutional holding update from MarketBeat, Keurig Dr Pepper, Inc last reported its quarterly results on August 6, 2026 for Q2 2026, delivering earnings per share of USD 0.57 versus a consensus estimate of USD 0.54. This EPS beat of USD 0.03 in Q2 2026 came alongside strong top-line growth, with revenue rising 75.6 percent year on year to USD 7.31 billion compared with analyst expectations of USD 7.23 billion.

The same Q2 2026 report shows that Keurig Dr Pepper generated a net margin of 7.10 percent and a return on equity of 10.80 percent, highlighting that profitability has scaled with the rapid revenue growth.MarketBeat Sell-side analysts as a group expect full-year 2026 EPS of about USD 2.30, implying that the Q2 2026 performance is broadly in line with the current earnings trajectory.

Institutional buying and insider activity frame the risk-reward

The latest filings indicate ongoing institutional interest in Keurig Dr Pepper stock. MarketBeat reports that Amundi recently purchased 1,705,572 shares of Keurig Dr Pepper, while a separate filing shows that the Saudi Central Bank acquired 42,712 shares, underscoring that large investors are building or expanding positions as the company delivers strong growth.MarketBeat

At the same time, insider activity introduces a counterpoint. Senior vice president Angela A. Stephens sold 9,500 shares at an average price of USD 32.70 per share on September 3, 2026, with the stock closing at USD 32.59 on September 4, 2026.Yahoo Finance While individual insider sales do not necessarily signal a change in fundamentals, they can remind investors to balance enthusiasm about institutional inflows with caution around valuation and timing.

Valuation, performance and market capitalization

On valuation metrics, MarketBeat data indicate that Keurig Dr Pepper trades at a price-to-earnings ratio of 32.92 based on current earnings, which is below the market-average multiple of about 39.29. That suggests investors are paying a premium for the company’s growth but not an extreme one relative to the broader market.

Performance metrics over different horizons provide further context. According to the latest stock overview, Keurig Dr Pepper’s share price was USD 28.01 on January 1, 2026 and has risen to USD 32.59 by September 4, 2026, an increase of approximately 16.4 percent year to date, while trailing total returns put the YTD gain at 19.19 percent compared with 12.75 percent for the S&P 500 over the same period.MarketBeatYahoo Finance This outperformance shows that the stock has rewarded shareholders in 2026 after more subdued multi-year returns.

From a size perspective, Keurig Dr Pepper’s market capitalization stands at about USD 44.34 billion as of early September 2026, placing it among the world’s roughly 600 most valuable companies by market cap.CompaniesMarketCap For investors, that scale suggests the business has meaningful resilience and liquidity, but still room for growth compared with larger global beverage peers.

Analyst targets and upcoming events

Analyst sentiment remains supportive. An overview of broker activity compiled by Business Insider shows that Keurig Dr Pepper stock carries a consensus rating of buy, with 37 buy recommendations, 11 hold ratings and just 1 sell rating across the analyst set. The median 12-month price target stands at USD 35.63, with the most optimistic target at USD 42.00 and the lowest at USD 26.00, implying upside potential from the recent USD 32.59 level if the company continues to execute.

Recent target actions include an upgrade to buy from HSBC with a price objective of USD 40, and maintained buy ratings with targets of USD 38 and USD 39 from Barclays Capital and UBS respectively, all dated in August 2026.Business Insider These targets collectively frame a band of expectations that cluster above the current share price, but investors will be watching whether upcoming data support such estimates.

On the calendar, MarketBeat lists Keurig Dr Pepper’s next earnings date as October 26, 2026, following the last earnings release on August 6, 2026, and notes company participation in the Barclays 19th Annual Global Consumer Conference on September 10, 2026. Both events represent near-term catalysts where management can update the market on progress and outlook.

Product focus: single-serve coffee systems as a growth driver

Keurig Dr Pepper’s results continue to be closely tied to its single-serve coffee system portfolio, including the Keurig brewing platform and its broad range of compatible beverage pods. These systems help generate recurring revenue both through hardware sales and the ongoing consumption of coffee, tea and specialty beverage pods, which is a key structural driver behind the growing revenue base noted in the Q2 2026 figures.Yahoo Finance

Trailing twelve-month revenue has risen to roughly USD 20.1 billion from around USD 12.5 billion in 2021, with year-over-year revenue growth averaging about 10.7 percent over this period.Yahoo Finance For investors, the combination of a strong branded coffee platform and expanding distribution in soft drinks and ready-to-drink beverages underpins the case that Keurig Dr Pepper can sustain mid to high single-digit revenue growth, even as competition in both coffee and sodas remains intense.

Stock level and one-year range

As of September 4, 2026, Keurig Dr Pepper stock closed at USD 32.59 on its primary listing on the Nasdaq exchange, down 0.88 percent on the day, with a modest additional move in overnight trading shortly after the close.Yahoo Finance The shares currently sit between their twelve-month low of USD 24.88 and their twelve-month high of USD 33.82, suggesting that the stock is trading relatively close to the top of its recent range while still below the absolute peak level.MarketBeat

With that price also near the median analyst target of USD 35.63, the market appears to be pricing in continued execution on earnings and revenue growth, while leaving some room for further appreciation if upcoming results and strategic moves, such as portfolio adjustments and potential corporate restructuring, continue to support the investment thesis.Business Insider

Keurig Dr Pepper stock key data

  • Company: Keurig Dr Pepper Inc.
  • ISIN: US49271V1008
  • Ticker: KDP
  • Trading venue: NASDAQ
  • Price (as of September 4, 2026, 16:00): 32.59 USD
  • Market capitalization: 44.34 billion USD (as of September 6, 2026)
  • Sector / Industry: Beverages / Soft drinks and coffee
  • Index membership: S&P 500
  • Next earnings date: October 26, 2026

More news and analyses on Keurig Dr Pepper stock

Disclaimer...

en | US49271V1008 | KEURIG DR PEPPER | boerse | 70069967 | bgmi